Liu Yejun, Tao Zezhang, Qu Jining, Zhou Xuhong, Zhang Chenghong
Department of Otolaryngology-Head and Neck Surgery, Renmin Hospital of Wuhan University, Wuhan 430060, Hubei Province, People's Republic of China.
Department of Otolaryngology-Head and Neck Surgery, Renmin Hospital of Wuhan University, Wuhan 430060, Hubei Province, People's Republic of China.
Biochem Biophys Res Commun. 2017 Sep 16;491(2):374-381. doi: 10.1016/j.bbrc.2017.07.093. Epub 2017 Jul 17.
While some long noncoding RNAs (lncRNAs) might promote nasopharyngeal carcinoma (NPC) initiation and progression, the involved molecular mechanisms remain largely unclear. Here, we discovered the novel LncRNA, prostate cancer associated transcript 7 (PCAT7), which was overexpressed and associated with worse prognosis in NPC. Decreased PCAT7 expression was found to significantly suppress tumor cell proliferation in vitro, and inhibited tumor growth and reduced the expression of proliferation antigen Ki-67 in vivo. Rescue assay was performed to further confirm that PCAT7 contributed to the progression of NPC through regulating miR-134-5p/ELF2 signal pathway. These results indicated that PCAT7 might contribute to the tumor progression in NPC by functioning as a ceRNA to sponge miR-134-5p.
虽然一些长链非编码RNA(lncRNAs)可能促进鼻咽癌(NPC)的起始和进展,但其涉及的分子机制在很大程度上仍不清楚。在此,我们发现了一种新型的LncRNA,前列腺癌相关转录本7(PCAT7),其在NPC中过表达且与较差的预后相关。发现PCAT7表达降低可显著抑制体外肿瘤细胞增殖,并在体内抑制肿瘤生长并降低增殖抗原Ki-67的表达。进行了挽救实验以进一步证实PCAT7通过调节miR-134-5p/ELF2信号通路促进NPC的进展。这些结果表明,PCAT7可能通过作为竞争性内源RNA(ceRNA)来海绵化miR-134-5p,从而促进NPC的肿瘤进展。